| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.36B | 28.27B | 28.47B | 27.33B | 24.86B | 25.63B |
| Gross Profit | 8.86B | 8.81B | 9.21B | 8.68B | 8.06B | 8.46B |
| EBITDA | 2.30B | 2.68B | 2.30B | 2.63B | 1.97B | 2.15B |
| Net Income | 1.06B | 1.33B | 713.57M | 1.17B | 566.22M | 521.80M |
Balance Sheet | ||||||
| Total Assets | 27.08B | 26.28B | 26.78B | 26.45B | 25.50B | 25.11B |
| Cash, Cash Equivalents and Short-Term Investments | 5.08B | 5.15B | 4.87B | 4.00B | 3.47B | 3.47B |
| Total Debt | 3.64B | 4.29B | 4.09B | 5.19B | 6.48B | 6.44B |
| Total Liabilities | 10.74B | 9.59B | 11.75B | 12.67B | 13.10B | 13.16B |
| Stockholders Equity | 16.34B | 16.69B | 15.03B | 13.79B | 12.41B | 11.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 362.29M | 2.18B | 1.98B | 65.57M | 1.34B |
| Operating Cash Flow | 0.00 | 516.56M | 2.46B | 2.27B | 437.38M | 1.80B |
| Investing Cash Flow | 0.00 | -256.65M | -551.73M | -310.00M | -636.56M | -429.14M |
| Financing Cash Flow | 0.00 | -216.60M | -1.42B | -1.56B | -168.16M | -970.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥14.32B | 2.21 | ― | 1.20% | -6.45% | 53.12% | |
74 Outperform | ¥330.61B | 9.83 | 5.53% | 3.55% | -5.43% | 55.21% | |
73 Outperform | ¥67.65B | 23.18 | ― | 2.73% | 6.41% | 16.71% | |
66 Neutral | ¥179.03B | 8.81 | 13.53% | 1.34% | 0.48% | -1.86% | |
66 Neutral | ¥90.28B | 12.03 | ― | 1.99% | 3.71% | -3.32% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | ¥390.66B | 5.68 | ― | ― | -10.88% | ― |